Close Menu

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that revenues in the third quarter grew 7 percent year over year.

For the three months ended Sept. 30 total revenues rose to $466.6 million from $435.6 million in Q3 2017, beating the consensus Wall Street estimate of $451.7 million.

The company saw a 1.5 percent positive effect from acquisitions and a 1.4 percent negative effect from currency effects on the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.

Apr
30
Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.